In the period 1988-1993, 241 patients had Klebsiella bacteraemia at our medical centre. The annual number of patients with positive blood cultures increased from 306 in 1988 to 622 in 1993, representing a 4.5-6% positivity rate of drawn cultures. After E. coli, Klebsiella was the leading cause of Gram-negative bacteraemia. During this period, the absolute number of Klebsiella bacteraemia increased from 25 in 1988 to 84 in 1993; this represents a true increase in Klebsiella bacteraemia, from 6 -7 % of positive cultures in the late 1980s to 12-13% in more recent years. There were 210 cases with K. pneumoniae and 31 with K. oxytoca. A representative sample of 80 records was retrieved and subdivided into two groups: communityacquired Klebsiella bacteraemia (CAKB) vs. hospitalacquired Klebsiella bacteraemia (HAKB). Urinary tract infection was the underlying source of 58% of CAKB vs. 28% of HAKB (p<0.01); pneumonia occurred significantly more often in HAKB (25%) than in CAKB (7%)(p<0.01). In HAKB, as compared to CAKB, serious manifestations of illness were more common, e.g. shock (65% vs. 37%, p< 0.046) and respiratory failure (45% vs. 20%, p< 0.046). Overall mortality was 32%; 22% of patients with CAKB died vs. 4 2 % of those with HAKB (p<0.05). Multiple drug resistance was very common: only 57% of all Klebsiella strains were susceptible to gentamicin, 66% to ceftriaxone, 70% to ciprofloxacin, and 83% to amikacin. The susceptibility rates of Klebsiella spp isolated from patients with HAKB were significantly lower ( p < 0.001). Sepsis due to multiple-drug-resistant Klebsiella has become frequent, carrying significant morbidity and mortality. Restriction of broad-spectrum antimicrobials in the hospital and the community as well as implementation of infection control measures are needed to contain this problem.
Introduction
Klebsiella is a common cause of Gram-negative sepsis, second only to Escherichia coli? causing between 5% and 29% of these infections in some university hospitals. 2 ' 3 Klebsiella is often considered a cause of nosocomial sepsis in particular. Infections with this species are associated with high morbidity and mortality. 4 The emergence of extended-spectrum beta-lactamases in Klebsiella and their dissemination have greatly complicated chemotherapy, and betalactam-resistant outbreaks have been reported in several countries. 5 " 8 Extensive use of late-generation cephalosporins, in particular, has been associated with emergence and dissemination of multiply-drugresistant Klebsiella strains. 6 In this study we describe a six-year survey of Klebsiella bacteraemia, with an ominously high rate of antimicrobial resistance, and the clinicalepidemiological features of 80 patients, comparing community-acquired with nosocomial sepsis.
Methods
This retrospective study was carried out in a 550-bed, community-oriented, university-affiliated hospital. It was precipitated by what appeared to be an increase in incidence of Klebsiella bacteraemia. Blood cultures were routinely drawn as a set, comprising an aerobic and anaerobic bottle, using the BACTEC 9240 system (Becton Dickinson); usually, two sets were drawn at one septic episode with 15-30min between the two sets. Microbial susceptibilities were determined by the Kirby-Bauer method. Minimal inhibitory concentrations were only determined if clinically required, using the E-test (Biodisk). Microbiology records, comprising blood stream isolates, were reviewed for all patients who had Klebsiella grown from blood cultures during the six-year period 1988-1993. Details, including date, gender, department, Klebsiella species, and microbial susceptibilities were collected and entered into a computer program (QuattroPro, Borland). Patients were entered only once, even if multiple blood cultures were positive with the same organism during one admission. Subsequently, an effort was made to retrieve the patients' medical records. From these records the following information was collected: gender, age, department, principal diagnosis upon admission, Klebsiella species, microbial susceptibilities, community vs. nosocomial origin (see below for definition), site of entry and clinical diagnosis, severity of the patient's condition at time of Klebsiella bacteraemia (including presence or absence of shock, acute renal failure, respiratory failure, and coma), antibiotic therapy, duration of admission and outcome.
Standard definitions of pneumonia, respiratory failure, acute renal failure and shock were employed throughout this study. 9 " 12 Multiple drug resistance refers to organisms resistant to gentamicin and at least one extended-spectrum beta-lactam antibiotic, e.g. ceftazidime or aztreonam. 13 Cases with polymicrobial bacteraemia were excluded from this study.
Patients with Klebsiella bacteraemia were all considered to have true bacteraemia, as opposed to pseudobacteraemia due to sampling error or laboratory contamination; the clinical data from these patients' records confirmed this approach.
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Bacteraemia was considered to be nosocomial if blood cultures taken after 72 h or more after admission were positive, and there appeared to be no obvious association between bacteraemia and the clinical condition of the patient at time of admission. We considered a particular organ as source of the bacteraemia if symptoms and/or signs were present indicating infection in the particular organ, and the same organism was cultured from a related clinical specimen. Data were entered into the computer program previously mentioned. Statistical significance was calculated with Student's t test and x 2 analysis.
Results
During the study period, the annual number of drawn blood cultures increased from 6800 in 1988 to more than 10 000 in 1993, reflecting the growing 'p<0.001. The other differences between the two groups were not statistically significant.
We were able to retrieve 99 patient records (99/241, 41%), of which 19 had insufficient clinical data. Therefore, a total of 80 records were available for evaluation. This appears to be a representative sample of the entire group of patients with Klebsiella bacteraemia as far as can be determined (Table 1) . However, there was under-representation of paediatric patients. The 80 patients with Klebsiella bacteraemia for whom complete records were available, were subdivided into two groups: community vs. hospital acquired bacteraemia. The clinical characteristics of these patients are shown in Table 2 . 37/40 patients (92%) with community-acquired Klebsiella bacteraemia lived at home, the remainder in nursing homes; 33/40 (82%) of patients with nosocomial bacteraemia lived at home, the remainder in nursing homes; this difference was statistically insignificant. Patients who died of Klebsiella bacteraemia died 14 + 22 days after diagnosis of community-acquired infection, compared with 13 + 16 days in the case of nosocomial infection. Antimicrobial susceptibilities of Klebsiella strains are shown in Table 3 ; a considerable decrease in susceptibility rates was noted during the study period (Figure 4 ).
Discussion
The incidence of bacteraemia has progressively increased during the last few decades and ranges from three to 25 cases per 1000 admissions, the average being about 10 per 1000 admissions. 8 despite the recently perceived increased incidence of Klebsiella bacteraemia at our institution, the percentage of bacteraemias due to these organisms was comparable to the numbers reported in the literature. 18 The increase was possibly due to the rising number of intensive care unit beds and commensurate number of sicker patients being taken care of in the hospital. This retrospective review of 80 patients with Klebsiella sepsis allowed us to make some clinical, epidemiological and laboratory observations (Tables  1 and 2 ). A few series of Klebsiella bacteraemia have been published in the last 25 years (Table 4) ; this allows for some comparison between our data and the data reported in the literature. 4 30 The majority (87%) of our patients had K. pneumoniae, similar to the 75-100% range reported in the majority of published series. Most of the patients in this study were elderly (66 + 23 years), and there was an almost equal distribution between the sexes ( Table 2 ). The majority of our patients were hospitalized in the medical and acute geriatric departments (39%) or intensive care units (30%). The most frequent associated illnesses in this study were urinary tract infection (42%) and pneumonia (16%); these percentages are similar to the 1 4 -3 1 % reported for urinary tract infections 15 ' 24 and 9-22% reported for pulmonary infections (Table 4) . 25 ' 30 In our series, Klebsiella sepsis was associated with serious morbidity, including shock (51%), acute renal failure (35%) and respiratory failure (32%); overall mortality was 32% (Table 2) . A common feature of all published series is the nosocomial origin of many of these reported instances, ranging from 20% 30 to almost 100%;
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50% of the patients in our study had hospitalacquired infection. Certain unique characteristics distinguished patients with community-acquired from nosocomial Klebsiella bacteraemia (Table 2) .
Hospital-acquired sepsis was significantly more often associated with pneumonia (25%, p<0.01); serious complications such as shock (65%) and respiratory failure (45%) were significantly more common (p<0.046), and mortality was higher in this group (42%, p<0.05). On the other hand, communityacquired Klebsiella sepsis is more often due to urinary tract infection (58%, p<0.01), and serious morbidity and mortality (22%) is much lower. Factors associated with poor prognosis included presence of septic shock, pneumonia, and inappropriate initial antimicrobial therapy. 8 33 However, plasmid-mediated resistance to these cephalosporins has been reported in many countries in the last few years, 34 " 39 and several nosocomial outbreaks have occurred due to these strains. Meyer et al. 6 recently described the capacity of ceftazidime-resistant K. pneumoniae to become established and cause serious infections within the hospital under the selective pressure of ceftazidime use despite an active antibiotic control program. Ceftazidime restriction and infection control meas- Urine (28) Bile (12) Lung (10) Bile (24) Lung (20) Urine (19) Urine (22) Lung (15) Urine (31) Lung (15) Bile (10) Lung (16) Urine (14) GIT (12) Bile/GIT (30) Urine (26) Lung (22) Urine (27) GIT (24) IV line (20) Lung (15) GIT ( Bile, biliary tract infection; Lung, pneumonia; GIT, gastrointestinal tract; NR, not reported.
ures effectively controlled that particular outbreak. However, the multiple-drug-resistant nature of many strains of K. pneumoniae may impair the responsiveness of an outbreak to the restriction of a single antibiotic, e.g. ceftazidime or imipenem. For instance, the continued use of amikacin may exert selective pressure to preserve amikacin-resistant K. pneumoniae. In addition, unrelated classes of antimicrobials, such as the quinolones, may select for deficiency of outer-membrane protein that may be responsible for beta-lactam transport in Klebsiella. 40 Thus, emergence of multiple-drugresistant K. pneumoniae may be due to selective pressure of different antibiotics and various resistance mechanisms.
With these considerations in mind one may view with particular concern the resistance patterns of the K. pneumoniae strains described in this study. Results of standard disc-diffusion testing of Klebsiella strains revealed that only 70% of organisms were susceptible to ciprofloxacin, 66% to ceftriaxone, and 57% to gentamicin (Table 3 ). Nosocomial infection due to gentamicin-resistant Klebsiella has been described as early as the early 1970s, 32 ' 41 however, in the mentioned series of Klebsiella sepsis in Western countries, gentamicin resistance was reported to vary between 2-5%. 14 ' 15 Ominously, in other countries, gentamicin resistance in Klebsiella spp may range from 19% 8 to 24%. 15 In our series, only 57% of all K. pneumoniae isolates were gentamicin-susceptible, with a range of 37% in nosocomial strains to 77% in communityacquired organisms. Multiple antibiotic resistance appears extraordinarily common in hospital-acquired K. pneumoniae, which may be related to heavy use and selective pressure of extended-spectrum betalactams, quinolones and amikacin. Resistance rates, although significantly less common than in nosocomial Klebsiella, were worryingly high among community-acquired strains as well. Possibly this is related to extensive usage of antimicrobial agents in the community. 42 The attributable mortality from nosocomial bloodstream infection is high in critically ill patients. This infection is associated with a doubling of the stay in the intensive care unit, an excess length of hospital stay of 24 days in survivors, and a significant economic burden. 20 Recognition is the first step in controlling the problem of nosocomial infections in general, and infections with multidrug-resistant organisms in particular. Preventing the emergence of these related issues is a complex issue; 43 Thirdly, infectious diseases physicians, clinical pharmacists and the infection control nurse conduct daily rounds in the various departments in order to decrease the spectrum of antimicrobial usage in individual patients. Fourthly, greater efforts are made to isolate patients with multidrug-resistant organisms. However, as in other centres, and despite all educational efforts, hand-washing is never done enough. Finally, the microbiology laboratory now preforms surveillance cultures, follows culture results from significant clinical specimens and microbial susceptibilities with computerized records, and determines presence of extended-spectrum beta-lactamases in isolates of K. pneumoniae. These efforts in turn lead to improved isolation of patients harbouring these organisms. We hope that these efforts will lead to decreased incidence of infections with multi-drugresistant K. pneumoniae. Î n conclusion, Klebsiella is second only to E. coli as a cause of Gram-negative bacteraemias. Community-acquired Klebsiella bacteraemia is most frequently associated with urinary tract infection, whereas nosocomial bacteraemia is usually associated with pneumonia, biliary tract pathology or unknown (primary) aetiology. Mortality remains high, despite proper antimicrobial treatment and supportive measures. Factors indicating poor prognosis include presence of pneumonia, shock and inadequate initial antimicrobial therapy. In hospitals with high prevalence of multiple-drug-resistant Klebsiella infections, initial therapy of suspected nosocomial sepsis should probably consist of a beta-lactam and an aminoglycoside. Patients known to harbour multiple-drug-resistant organisms should be isolated. 45 Hospitals should restrict usage of antimicrobials known to exert excessive selective pressure, e.g. third-generation cephalosporins. Antibiotic usage in the community should also be controlled, in order to diminish emergence of multiple-drug-resistant organisms in the community as well.
